Skip to main content
Download PDF

Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis

BMC Women's Health volume 23, Article number: 352 (2023) Cite this article

Abstract

Objective

To estimate the pooled prevalence of sexual dysfunction (SD) in women with multiple sclerosis (MS).

Methods

We systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar and also gray literature up to October 2021.

The search strategy includes:

(“Multiple Sclerosis” OR “MS” OR “Disseminated Sclerosis” OR (Disseminated AND Sclerosis) OR (Sclerosis AND Multiple)) AND (“Sexual Dysfunction” OR (Sexual AND Dysfunction) OR (Sexual AND Dysfunctions) OR (Sexual AND Disorders) OR (Sexual AND Disorder) OR “Sexual Dysfunctions” OR “Sexual Disorders” OR “Sexual Disorder” OR “Psychosexual Dysfunctions” OR (Dysfunction AND Psychosexual) OR (Dysfunctions AND Psychosexual) OR “Psychosexual Dysfunction” OR “Psychosexual Disorders” OR (Disorder AND Psychosexual) OR (Disorders AND Psychosexual) OR “Psychosexual Disorder” OR “Hypoactive Sexual Desire Disorder” OR “Sexual Aversion Disorder” OR (Aversion Disorders AND Sexual) OR (Disorders AND Sexual Aversion) OR “Sexual Aversion Disorders” OR “Orgasmic Disorder” OR (Disorders AND Orgasmic) OR “Orgasmic Disorders” OR “Sexual Arousal Disorder” OR (Arousal Disorders AND Sexual) OR (Disorders AND Sexual Arousal) OR “Sexual Arousal Disorders” OR “Frigidity”).

Results

We found 2150 articles by literature search, after deleting duplicates 1760 remained. Fifty-six articles remained for meta-analysis. The pooled prevalence of SD in MS patients estimated as 61% (95%CI:56–67%) (I2:95.7%, P < 0.001). The pooled prevalence of Anorgasmia in MS patients estimated as 29% (95%CI:20–39%) (I2:85.3%, P < 0.001). The pooled odds of developing SD in MS women estimated as 3.05(95%CI: 1.74–5.35) (I2:78.3%, P < 0.001). The pooled prevalence of decreased vaginal lubrication in MS patients estimated as 32%(95%CI:27–37%) (I2 = 94.2%, P < 0.001). The pooled prevalence of reduced libido was 48%(95%CI:36–61%) (I2:92.6%, P < 0.001). The pooled prevalence of arousal problems was 40%(95%CI: 26–54%) (I2:97.4%, P < 0.001). The pooled prevalence of intercourse satisfaction was 27% (95%CI: 8–46%) (I2:99%, P < 0.001).

Conclusion

The result of this systematic review and meta-analysis show that the pooled prevalence of SD in women with MS is 61% and the odds of developing SD in comparison with controls is 3.05.

Peer Review reports

Introduction

Multiple sclerosis (MS) is a degenerative, neurologic disease of the central nervous system (CNS) affecting women more than men [1]. It usually occurs between 20 and 50 years of age, while MS-related complications include both physical and psychological consequences [2]. One of the most common multi-dimensional complications is sexual dysfunction (SD) involving physiological, psychosocial, and interpersonal factors [3]. It is suggested that women with MS have problems regarding finding a partner, building a relationship, and marital issues [3]. SD has negative impacts on health-related quality of life (HRQoL), especially on youth [4, 5]. It can be found at any stages of the disease, and is present at early stage in some cases [6, 7]. The exact etiology of SD in MS is not clear, but physical disability, psychological difficulties, and also side effects of medications could cause SD [8, 9].

Primary SD is the consequence of neurological changes in the body, while secondary SD is due to MS-related complications such as fatigue, pain, spasticity, bladder, and bowel dysfunction [10]. Tertiary SD is related to psychological consequences of MS such as depression, anxiety, and cognitive impairment / and cultural issues regarding sexual consultant in different nations [10].

Loss of orgasm, libido, lubrication, and increased spasticity are common during sexual activity in women with MS  [11, 12].

Different factors such as age, disease duration, disability level, bladder dysfunction, cognitive impairment, and disease course influence SD in MS women [13,14,15].

Up to now, different original studies have been conducted and three previous systematic reviews and meta-analyses estimated the pooled prevalence of SD in women with MS [16,17,18]. The aim of this system and meta-analysis is to update the prevalence of SD in MS women.

Methods

Eligibility criteria

Inclusion criteria were

Cross-sectional studies, Articles that had been published in the English language.

Exclusion criteria

Case-report, RCT studies.

We followed The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 for reporting this systematic review [19].

Information sources

Two independent researchers systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar and also gray literature up to October 2021.

The search strategy includes

(“Multiple Sclerosis” OR “MS” OR “Disseminated Sclerosis” OR (Disseminated AND Sclerosis) OR (Sclerosis AND Multiple)) AND (“Sexual Dysfunction” OR (Sexual AND Dysfunction) OR (Sexual AND Dysfunctions) OR (Sexual AND Disorders) OR (Sexual AND Disorder) OR “Sexual Dysfunctions” OR “Sexual Disorders” OR “Sexual Disorder” OR “Psychosexual Dysfunctions” OR (Dysfunction AND Psychosexual) OR (Dysfunctions AND Psychosexual) OR “Psychosexual Dysfunction” OR “Psychosexual Disorders” OR (Disorder AND Psychosexual) OR (Disorders AND Psychosexual) OR “Psychosexual Disorder” OR “Hypoactive Sexual Desire Disorder” OR “Sexual Aversion Disorder” OR (Aversion Disorders AND Sexual) OR (Disorders AND Sexual Aversion) OR “Sexual Aversion Disorders” OR “Orgasmic Disorder” OR (Disorders AND Orgasmic) OR “Orgasmic Disorders” OR “Sexual Arousal Disorder” OR (Arousal Disorders AND Sexual) OR (Disorders AND Sexual Arousal) OR “Sexual Arousal Disorders” OR “Frigidity”).

Selection process

After obtaining the results, and importing them to Endnote, they omitted duplicates. Then titles, and abstracts were screening, and potential full texts were obtained. The researchers extracted data from each study, entered in Excel, and in the case of discrepancies, the third researcher solved the problem.

Data items

Data regarding first author, country of origin, number of enrolled patients, number of cases with SD, mean age, mean EDSS, mean duration of the disease, were collected.

Statistical analysis

All statistical analyses were performed using STATA (Version 14.0; Stata Corp LP, College Station, TX, USA). To determine heterogeneity, Inconsistency (I2) was calculated.

We used random effects model.

Effect measures

The pooled prevalence of domains of sexual function were estimated. The pooled odds ratio(OR) of developing sexual dysfunction in women with MS comparing to healthy controls were calculated.

Results

We found 2150 articles by literature search, after deleting duplicates 1760 remained. Fifty-six articles remained for meta-analysis (Fig. 1).

Fig. 1
figure 1

Flow diagram summarizing the selection of eligible studies

Full size image

Included studies were published between 1996, and 2021.Most included studies were from Iran, followed by Italy, and Turkey. The mean age of participants ranged between 24.7, and 50.7 years, and EDSS ranged between 1.7 and 5. The most frequent applied questionnaire was FSFI (Table 1).

Table 1 Basic characteristics of included studies
Full size table

Totally 8980 patients were evaluated and the total number of patients with SD was 4245.

The pooled prevalence of SD in MS patients estimated as 61% (95%CI:56–67%) (I2:95.7%, P < 0.001) (Fig. 2).

Fig. 2
figure 2

The pooled prevalence of SD in MS patients

Full size image

The pooled prevalence of Anorgasmia in MS patients estimated as 29% (95%CI:20–39%) (I2:85.3%, P < 0.001) (Fig. 3).

Fig. 3
figure 3

The pooled prevalence of anorgasmia in MS patients

Full size image

The pooled prevalence of decreased vaginal lubrication in MS patients estimated as 32%(95%CI:27–37%) (I2 = 94.2%, P < 0.001) (Fig. 4).

Fig. 4
figure 4

The pooled prevalence of decreased vaginal lubrication in MS patients

Full size image

The pooled prevalence of reduced libido was 48%(95%CI:36–61%) (I2:92.6%, P < 0.001) (Fig. 5).

Fig. 5
figure 5

The pooled prevalence of reduced libido in MS patients

Full size image

The pooled prevalence of intercourse satisfaction was 27% (95%CI: 8–46%) (I2:99%, P < 0.001) (Fig. 6).

Fig. 6
figure 6

The pooled prevalence of reduced libido in MS patients

Full size image

The pooled prevalence of arousal problems was 40%(95%CI: 26–54%) (I2:97.4%, P < 0.001) (Fig. 7).

Fig. 7
figure 7

The pooled prevalence of arousal problems in MS patients

Full size image

The pooled odds of developing SD in MS women estimated as 3.05(95%CI: 1.74–5.35) (I2:78.3%, P < 0.001) (Fig. 8).

Fig. 8
figure 8

The pooled odds of developing SD in women with compared to healthy controls

Full size image

Discussion

MS is a neurological disease characterized by a wide range of physical, and psychological complications. The prevalence of SD in MS is near five times higher than general population [12, 66], although it is considered poorly in this population.

To our knowledge, this is the first comprehensive systematic review and meta-analysis including all related studies evaluating SD in women with MS. We included all studies which used different questionnaires. The pooled prevalence of SD was estimated as 61%, and the most common SD complaint was reduced libido (the pooled prevalence was estimated as 48%), we also found that the pooled prevalence of intercourse satisfaction was 27%.

We included all studies which applied different diagnostic tools, so out estimate would be higher than previous ones.

In a previous systematic review and meta-analysis which was conducted by Zhao et al., the relative risk (RR) of developing SD in MS women was 1.87 which shows that women with MS have 87% increased risk of developing SD [16]. They also reported lower pooled scores of desires, arousal, orgasm, satisfaction, pain, and lubrication in MS group.

In our previous systematic review, which we included only studies that applied FSFI questionnaire for evaluating SD in MS, the pooled prevalence of SD estimated as 55% [18].

In 2008, Tzorts et al. evaluated 63 women with MS using FSFI questionnaire, and reported SD in22 and reported no depression in affected cases [7].

Zorzon et al. used Szasz Sexual Functioning Scale for SD assessment and reported SD in 44 out of 70 cases. Anorgasmia or hyporgasmia followed by decreased vaginal lubrication were the most affected subscales [12].

The variation about the prevalence of SD in included studies is due to unclear definition of SD, diverse inclusion, and exclusion criteria, various diagnostic methods, no standardized tools, and cultural issues.

SD is an important issue in marital life which is ignored by most physicians and patients. It is a multi-dimensional issue which affects quality of life as well as psychological well-being. Different factors such as disease duration, disability level, psychological disorders such as depression, anxiety, and stress are considered to play role in SD development in MS while there is controversies between studies [11].

Most physicians do not pay attention to this part of their patient’s lives, and patients hesitate to talk about intimate issues.

Depression is negatively correlated with FSFI score and its subscales in a previous original study [11]. On the other hand, it is shown that depression is related with both libido reduction and arousal problems [67, 68].

In another study, higher age was associated with increased SD prevalence in MS [69] while Çelik et al. reported that SD should be evaluated in MS women at earlier stages and disease duration or disability level are not prognostic factors for developing SD [13]. Zhao et al. in their meta-analysis showed that disease duration longer than ten years, increases the risk of SD 2.5fold in MS cases [16].

Another influencing factor is bladder dysfunction in MS cases which negatively affects their sexual activity [70]. Fragala et al. investigated SD in 91% of MS women with detrusor over-activity and 66% without detrusor over-activity [62].

The association refers to S2, S3 and S4 innervation of bladder, which control sexual response [10]. On the other hand, detrusor dysfunction as a MS-related complication may reflect severe neurological disability and SD [71].

Zivadinov et al. investigated that physical disorders, depression, age at MS onset, and also neurological impairment while they reported no correlation between SD and duration of the disease [15].

Higher disability level, depression and anxiety were related with SD presence in Demirkian et al. study [72].

This systematic review has some strength. First, we included all studies which evaluated SD. Second, the number of included studies is high. Third, we analyzed all subscales of SD.

We also had some limitations. First, all included studies used various diagnostic tools. Second, there was no clear definition of SD. Third, inclusion criteria of participants differed between studies.

Conclusion

The result of this systematic review and meta-analysis show that the pooled prevalence of SD in women with MS is 61% and the odds of developing SD in comparison with controls is 3.05.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

References

  1. Ghajarzadeh M, Foroushani AR, Ghezelbash P, Ghoreishi A, Maghbooli M, Yousefi M, et al. Prevalence of multiple sclerosis (MS) in Zanjan province of Iran. Int J Prev Med. 2020;11:116.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Askari F, Ghajarzadeh M, Jalilian R, Azimi A, Togha M, Sahraian MA, et al. Comparison of sexual dysfunction in women with migraine and multiple sclerosis (MS). Maedica. 2016;11(1):44.

    PubMed  PubMed Central  Google Scholar 

  3. Bronner G, Elran E, Golomb J, Korczyn A. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand. 2010;121(5):289–301.

    Article  PubMed  Google Scholar 

  4. Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA, et al. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler J. 2014;20(5):610–6.

    Article  Google Scholar 

  5. Tepavcevic D, Kostic J, Basuroski I, Stojsavljevic N, Pekmezovic T, Drulovic J. The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler J. 2008;14(8):1131–6.

    Article  CAS  Google Scholar 

  6. Donze C, Hautecoeur P. Urinary, sexual, and bowel disorders in early-stage multiple sclerosis. Rev Neurol. 2009;165:S148–55.

    PubMed  Google Scholar 

  7. Tzortzis V, Skriapas K, Hadjigeorgiou G, Mitsogiannis I, Aggelakis K, Gravas S, et al. Sexual dysfunction in newly diagnosed multiple sclerosis women. Mult Scler J. 2008;14(4):561–3.

    Article  Google Scholar 

  8. Askari F, Ghajarzadeh M, Mohammadifar M, Azimi A, Sahraian MA, Owji M. Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Med Iran. 2014;52:889–92.

    PubMed  Google Scholar 

  9. Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances iniranian patients with multiple sclerosis. 2012.

  10. Drulovic J, Kisic-Tepavcevic D, Pekmezovic T. Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis. Acta Neurol Belg. 2020;120:791–7.

    Article  PubMed  Google Scholar 

  11. Ghajarzadeh M, Jalilian R, Mohammadifar M, Sahraian MA, Azimi A. Sexual function in women with multiple sclerosis. Acta Med Iran. 2014;52:315–8.

    PubMed  Google Scholar 

  12. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, et al. Sexual dysfunction in multiple sderosis: a case-control study. 1. Frequency and comparison of groups. Mult Scler J. 1999;5(6):418–27.

    CAS  Google Scholar 

  13. Çelik DB, Poyraz EÇ, Bingöl A, İdiman E, Özakbaş S, Kaya D. Sexual dysfunction ın multiple sclerosis: gender differences. J Neurol Sci. 2013;324(1–2):17–20.

    Article  PubMed  Google Scholar 

  14. Fraser C, Mahoney J, McGurl J. Correlates of sexual dysfunction in men and women with multiple sclerosis. J Neurosci Nurs. 2008;40(5):312–7.

    Article  PubMed  Google Scholar 

  15. Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, et al. Sexual dysfunction in multiple sderosis: II. Correlation analysis. Mult Scler J. 1999;5(6):428–31.

    CAS  Google Scholar 

  16. Zhao S, Wang J, Liu Y, Luo L, Zhu Z, Li E, et al. Association between multiple sclerosis and risk of female sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2018;15(12):1716–27.

    Article  PubMed  Google Scholar 

  17. Polat Dunya C, Tulek Z, Uchiyama T, Haslam C, Panicker JN. Systematic review of the prevalence, symptomatology and management options of sexual dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2020;39(1):83–95.

    Article  PubMed  Google Scholar 

  18. Azimi A, Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M. Prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Maedica. 2019;14(4):408.

    PubMed  PubMed Central  Google Scholar 

  19. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.

    Article  PubMed  Google Scholar 

  20. Zorzon M, Zivadinov R, Bragadin LM, Moretti R, De Masi R, Nasuelli D, et al. Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci. 2001;187(1–2):1–5.

    Article  CAS  PubMed  Google Scholar 

  21. Darija K-T, Tatjana P, Goran T, Nebojsa S, Irena D, Sarlota M, et al. Sexual dysfunction in multiple sclerosis: a 6-year follow-up study. J Neurol Sci. 2015;358(1–2):317–23.

    Article  Google Scholar 

  22. McCabe MP, McDonald E, Deeks AA, Vowels LM, Cobain MJ. The impact of multiple sclerosis on sexuality and relationships. J Sex Res. 1996;33(3):241–8.

    Article  Google Scholar 

  23. Zavoreo I, Gržinčić T, Preksavec M, Madžar T, Bašić Kes V. Sexual dysfunction and incidence of depression in multiple sclerosis patients. Acta Clin Croatica. 2016;55(3):402–6.

    Article  Google Scholar 

  24. Kołtuniuk A, Przestrzelska M, Karnas A, Rosińczuk J. The association between sexual disorders and the quality of life of woman patients with multiple sclerosis: findings of a prospective, observational, and cross-sectional survey. Sex Med. 2020;8(2):297–306.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lew-Starowicz M, Rola R. Prevalence of sexual dysfunctions among women with multiple sclerosis. Sex Disabil. 2013;31(2):141–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Nortvedt M, Riise T, Myhr K, Landtblom A-M, Bakke A, Nyland H. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler J. 2001;7(4):231–5.

    Article  CAS  Google Scholar 

  27. Sacco E, Sebastianelli A, Batocchi AP, Pinto F, Totaro A, Volpe A, et al. Sexual dysfunctions in patients affected by multiple sclerosis: evaluation in a contemporary cohort from a referral center. 26th annual EAU congress 2011. Italy: Elsevier Science BV; 2011.

  28. Vazirinejad R, Lilley J, Ward C. A health profile of adults with multiple sclerosis living in the community. Mult Scler J. 2008;14(8):1099–105.

    Article  CAS  Google Scholar 

  29. Wu J, Jelinek GA, Weiland T, Hedström AK, Alfredsson L, Neate S, et al. Perceived cognitive impairment is associated with sexual dysfunction in people with multiple sclerosis: a 2.5-year follow-up study of a large international cohort. Mult Scler Relat Disord. 2020;45:102410.

    Article  PubMed  Google Scholar 

  30. Tulek Z, Durna Z, Eraksoy M. Exploring sexual problems among patients with multiple sclerosis. 2011.

  31. Nortvedt M, Riise T, Frugaård J, Mohn J, Bakke A, Skår A, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler J. 2007;13(1):106–12.

    Article  CAS  Google Scholar 

  32. Marck CH, Jelinek PL, Weiland TJ, Hocking JS, De Livera AM, Taylor KL, et al. Sexual function in multiple sclerosis and associations with demographic, disease and lifestyle characteristics: an international cross-sectional study. BMC Neurol. 2016;16(1):1–9.

    Article  Google Scholar 

  33. Merghati-Khoei E, Qaderi K, Amini L, Korte JE. Sexual problems among women with multiple sclerosis. J Neurol Sci. 2013;331(1–2):81–5.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ghasemi V, Simbar M, Ozgoli G, Nabavi SM, Majd HA. Prevalence, dimensions, and predictor factors of sexual dysfunction in women of Iran Multiple Sclerosis Society: a cross-sectional study. Neurol Sci. 2020;41(5):1105–13.

    Article  PubMed  Google Scholar 

  35. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler. 2006;12(2):209–14.

    Article  CAS  PubMed  Google Scholar 

  36. Abdo S, Adly M, Elmehdawy K, Alfaqeeh A, Hamdy S, Naseer MA, et al. Sexual dysfunction in women with early multiple sclerosis. Management. 2020;4:4.

    Google Scholar 

  37. Contentti EC, Pettinicchi JP, Caride A, López PA. Sexual dysfunction in patients with multiple sclerosis from Argentina: what are the differences between women and men? Sex Disabil. 2019;37(4):521–39.

    Article  Google Scholar 

  38. Altmann P, Leutmezer F, Leithner K, Monschein T, Ponleitner M, Stattmann M, et al. Predisposing factors for sexual dysfunction in multiple sclerosis. Front Neurol. 2021;12:618370.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ashtari F, Rezvani R, Afshar H. Sexual dysfunction in women with multiple sclerosis: dimensions and contributory factors. J Res Med Sci. 2014;19(3):228.

    PubMed  PubMed Central  Google Scholar 

  40. Qaderi K, Khoei EM. Sexual problems and quality of life in women with multiple sclerosis. Sex Disabil. 2014;32(1):35–43.

    Article  Google Scholar 

  41. Salhofer-Polanyi S, Wöber C, Prohazka R, Dal-Bianco A, Bajer-Kornek B, Zebenholzer K. Similar impact of multiple sclerosis and migraine on sexual function in women. Wien Klin Wochenschr. 2017;129(3–4):115–20.

    Article  PubMed  Google Scholar 

  42. Pašiü H, Vujeviü L, Pašiü MB, Mustaþ F, Rajiþ F, Vidrih B, et al. Sexual dysfunction and depression in patients with multiple sclerosis in Croatia. Psychiatr Danub. 2019;31(5):S831–8.

    Google Scholar 

  43. Stenager E, Stenager E, Jensen K. Sexual function in multiple sclerosis. A 5-year follow-up study. Italian J Neurol Sci. 1996;17(1):67–9.

    Article  CAS  Google Scholar 

  44. McCabe MP. Relationship functioning and sexuality among people with multiple sclerosis. J Sex Res. 2002;39(4):302–9.

    Article  PubMed  Google Scholar 

  45. McCabe MP, McKern S, McDonald E, Vowels LM. Changes over time in sexual and relationship functioning of people with multiple sclerosis. J Sex Marital Ther. 2003;29(4):305–21.

    Article  PubMed  Google Scholar 

  46. Dupont S. Sexual function and ways of coping in patients with multiple sclerosis and their partners. Sex Marital Ther. 1996;11(4):359–72.

    Article  Google Scholar 

  47. Hösl KM, Deutsch M, Wang R, Roy S, Winder K, Niklewski G, et al. Sexual dysfunction seems to trigger depression in female multiple sclerosis patients. Eur Neurol. 2018;80(1–2):34–41.

    Article  PubMed  Google Scholar 

  48. Nazari F, Shaygannejad V, Mohammadi Sichani M, Mansourian M, Hajhashemi V. Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life. BMC Urol. 2020;20(1):1–10.

    Google Scholar 

  49. Bartnik P, Wielgoś A, Kacperczyk J, Pisarz K, Szymusik I, Podlecka-Piętowska A, et al. Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis. Brain Behav. 2017;7(6):e00699.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Popek M, Grabowska-Popek A, Mitosek-Szewczyk K, Stelmasiak Z. Is multiple sclerosis only a neurological problem? Evaluation of sexual dysfunctions in a group of multiple sclerosis patients. Med Studies/Stud Med. 2018;34(2):127–32.

    Google Scholar 

  51. Firdolas F, Ozan T, Onur R, Bulut S, Orhan I. Evaluation of sexual function in women at two stages of multiple sclerosis. World J Urol. 2013;31(4):929–33.

    Article  PubMed  Google Scholar 

  52. Gava G, Visconti M, Salvi F, Bartolomei I, Seracchioli R, Meriggiola MC. Prevalence and psychopathological determinants of sexual dysfunction and related distress in women with and without multiple sclerosis. J Sex Med. 2019;16(6):833–42.

    Article  PubMed  Google Scholar 

  53. Gruenwald I, Vardi Y, Gartman I, Juven E, Sprecher E, Yarnitsky D, et al. Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing. Mult Scler J. 2007;13(1):95–105.

    Article  Google Scholar 

  54. Konstantinidis C, Tzitzika M, Bantis A, Nikolia A, Samarinas M, Kratiras Z, et al. Female sexual dysfunction among Greek women with multiple sclerosis: correlations with organic and psychological factors. Sex Med. 2019;7(1):19–25.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Lombardi G, Celso M, Bartelli M, Cilotti A, Del Popolo G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J Sex Med. 2011;8(4):1138–46.

    Article  CAS  PubMed  Google Scholar 

  56. Mohammadi K, Rahnama P, Mohseni SM, Sahraian MA, Montazeri A. Determinants of sexual dysfunction in women with multiple sclerosis. BMC Neurol. 2013;13(1):1–6.

    Article  Google Scholar 

  57. Alehashemi A, Mostafavian Z, Dareini N. Sexual function in Iranian female multiple sclerosis patients. Open Access Maced J Med Sci. 2019;7(8):1303.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Ramezani M, Hajiseyedsadeghi M, Ghaemmaghami A. 236 Sexual dysfunction and marital satisfaction in multiple sclerosis. J Sex Med. 2018;15(7):S215.

    Article  Google Scholar 

  59. Scheepe JR, Alamyar M, Pastoor H, Hintzen RQ, Blok BF. Female sexual dysfunction in multiple sclerosis: Results of a survey among Dutch urologists and patients. Neurourol Urodyn. 2017;36(1):116–20.

    Article  PubMed  Google Scholar 

  60. Koehn J, Linker R, Intravooth T, Crodel C, Deutsch M, Lee D-H, et al. Multiple Sclerosis Compromises Various Aspects of Female Sexual Function (P6. 166). Germany: AAN Enterprises; 2014.

  61. Solmaz V, Ozlece HK, Him A, Güneş A, Cordano C, Aksoy D, et al. Evaluation of the association between sexual dysfunction and demyelinating plaque location and number in female multiple sclerosis patients. Neurol Res. 2018;40(8):683–8.

    PubMed  Google Scholar 

  62. Fragala E, Russo G, Di Rosa A, Giardina R, Privitera S, Favilla V, et al. Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction. Eur J Neurol. 2015;22(3):485–92.

    Article  CAS  PubMed  Google Scholar 

  63. Petersen M, Kristensen E, Giraldi L, Giraldi A. Sexual dysfunction and mental health in patients with multiple sclerosis and epilepsy. BMC Neurol. 2020;20(1):1–9.

    Article  Google Scholar 

  64. Kılıc B, Unver V, Bolu A, Demirkaya S. Sexual dysfunction and coping strategies in multiple sclerosis patients. Sex Disabil. 2012;30(1):3–13.

    Article  Google Scholar 

  65. Calabrò RS, Russo M, Dattola V, De Luca R, Leo A, Grisolaghi J, et al. Sexual function in young individuals with multiple sclerosis: does disability matter? J Neurosci Nurs. 2018;50(3):161–6.

    Article  PubMed  Google Scholar 

  66. Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet. 2007;369(9560):512–25.

    Article  PubMed  Google Scholar 

  67. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13 Suppl 6:S1-4.

    Article  CAS  PubMed  Google Scholar 

  68. Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42(11):1098–104.

    Article  CAS  PubMed  Google Scholar 

  69. Timkova V, Mikula P, Linkova M, Szilasiova J, Nagyova I. Sexual functioning in patients with multiple sclerosis and its association with social support and self-esteem. Psychol Health Med. 2021;26(8):980–90.

    Article  PubMed  Google Scholar 

  70. DasGupta R, Fowler CJ. Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol. 2002;15(3):271–8.

    Article  PubMed  Google Scholar 

  71. Fragalà E, Privitera S, Giardina R, Di Rosa A, Russo GI, Favilla V, et al. Determinants of sexual impairment in multiple sclerosis in male and female patients with lower urinary tract dysfunction: results from an Italian cross-sectional study. J Sex Med. 2014;11(10):2406–13.

    Article  PubMed  Google Scholar 

  72. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler J. 2006;12(2):209–11.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Isfahan University of Medical Sciences, Isfahan, Iran

    Amid Yazdani

  2. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

    Narges Ebrahimi & Omid Mirmosayyeb

  3. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran

    Mahsa Ghajarzadeh

Authors
  1. Amid Yazdani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Narges Ebrahimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Omid Mirmosayyeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahsa Ghajarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.Y: Study design and data analysis. N.E: Data gathering and article writing. O.M: Data analysis and article writing. M.G: Methodology and article writing. All authors reviewed the manuscript.

Corresponding author

Correspondence to Mahsa Ghajarzadeh.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yazdani, A., Ebrahimi, N., Mirmosayyeb, O. et al. Prevalence and risk of developing sexual dysfunction in women with multiple sclerosis (MS): a systematic review and meta-analysis. BMC Women's Health 23, 352 (2023). https://doi.org/10.1186/s12905-023-02501-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-023-02501-1

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us